Concentrix (NASDAQ:CNXC) Given Outperform Rating at Barrington Research

Barrington Research reissued their outperform rating on shares of Concentrix (NASDAQ:CNXC) in a report issued on Tuesday,Benzinga reports. Barrington Research currently has a $62.00 price target on the stock.

Other equities research analysts have also recently issued research reports about the stock. Weiss Ratings cut shares of Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a report on Thursday, January 29th. Robert W. Baird set a $52.00 price objective on Concentrix in a report on Wednesday, January 14th. Finally, Wall Street Zen raised Concentrix from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th. Three investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $63.75.

Concentrix Stock Up 2.9%

CNXC stock opened at $32.90 on Tuesday. The stock has a market cap of $2.02 billion, a P/E ratio of -1.58, a P/E/G ratio of 0.34 and a beta of 0.50. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.67. The stock’s fifty day simple moving average is $36.48 and its two-hundred day simple moving average is $41.10. Concentrix has a 1-year low of $29.35 and a 1-year high of $66.00.

Concentrix (NASDAQ:CNXC) last announced its earnings results on Tuesday, January 13th. The company reported $2.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.93 by $0.02. The firm had revenue of $2.55 billion during the quarter, compared to analyst estimates of $2.54 billion. Concentrix had a positive return on equity of 16.91% and a negative net margin of 13.02%.The business’s revenue was up 4.3% compared to the same quarter last year. During the same period last year, the firm posted $3.26 EPS. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. Analysts expect that Concentrix will post 10.11 EPS for the current year.

Concentrix Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, February 10th. Investors of record on Friday, January 30th were paid a dividend of $0.36 per share. The ex-dividend date was Friday, January 30th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 4.4%. Concentrix’s payout ratio is -6.91%.

Insiders Place Their Bets

In other news, CEO Christopher A. Caldwell bought 1,000 shares of the company’s stock in a transaction that occurred on Thursday, January 29th. The stock was bought at an average price of $37.07 per share, with a total value of $37,070.00. Following the acquisition, the chief executive officer owned 362,075 shares of the company’s stock, valued at approximately $13,422,120.25. This represents a 0.28% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.90% of the company’s stock.

Hedge Funds Weigh In On Concentrix

A number of hedge funds have recently made changes to their positions in the business. Huntington National Bank grew its holdings in Concentrix by 6,011.1% during the 3rd quarter. Huntington National Bank now owns 550 shares of the company’s stock valued at $25,000 after buying an additional 541 shares in the last quarter. Geneos Wealth Management Inc. boosted its position in shares of Concentrix by 532.7% during the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after acquiring an additional 522 shares during the last quarter. Quent Capital LLC bought a new position in shares of Concentrix during the third quarter worth $29,000. Larson Financial Group LLC grew its stake in Concentrix by 224.9% during the third quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock valued at $32,000 after acquiring an additional 479 shares in the last quarter. Finally, Rothschild Investment LLC grew its stake in Concentrix by 14,980.0% during the third quarter. Rothschild Investment LLC now owns 754 shares of the company’s stock valued at $35,000 after acquiring an additional 749 shares in the last quarter. Institutional investors own 90.34% of the company’s stock.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.